Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its Covid-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters. The company has committed to deliver 200 million doses of its vaccine to the bloc this year. “We don’t really know how much to expect,” the EU official said. AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. Under the contract with J&J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the US firm.

Source: The Irish Times March 09, 2021 14:48 UTC